{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:16:23Z","timestamp":1792343783537,"version":"4.4.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The relationship between sarcopenia and clinical outcomes in patients with bladder cancer (BC) has been inconsistently reported in the literature. Some studies have identified sarcopenia as a potential prognostic indicator associated with reduced survival following radical cystectomy (RC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study was conducted to systematically evaluate the prognostic significance of sarcopenia in patients with bladder cancer undergoing RC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Systematic review and meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a comprehensive search of multiple databases, including PubMed, EMBASE, Web of Science, Cochrane Library, CHINAHL, China National Knowledge Infrastructure (CNKI) Databases, and Wanfang Database, up to August 23, 2023, to identify both retrospective and prospective cohort studies. To assess the methodological quality of the included studies, the Newcastle-Ottawa Scale was utilized to evaluate the risk of bias. Furthermore, heterogeneity and potential publication bias were examined, and both subgroup and sensitivity analyses were performed to ensure the robustness of the findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 18 studies comprising 3,110 patients were included in the quantitative synthesis. The results of meta-analysis showed that the pooled prevalence of sarcopenia was estimated to be 49% (95% CI: 41% to 57%, I<jats:sup>2<\/jats:sup> = 95.3%, P &amp;lt; 0.001), which was based on a random-effects model. We observed that BC patients with sarcopenia had a worse OS (HR:1.64, 95% CI: 1.30 to 1.97, I<jats:sup>2<\/jats:sup> = 76.5%, P &amp;lt; 0.001} and CSS (HR:1.86, 95% CI: 1.45 to 2.27, I<jats:sup>2<\/jats:sup> = 0.0%, P &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sarcopenia is commonly observed among patients with bladder cancer and appears to be an important prognostic indicator associated with decreased OS and CSS in those undergoing radical cystectomy. Further prospective studies are warranted to validate these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42023456724.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1642833","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:10Z","timestamp":1758168730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and prognostic value of sarcopenia in patients with bladder cancer undergoing radical cystectomy: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urology.2006.10.040","article-title":"Muscle-invasive urothelial carcinoma of the bladder","volume":"69","author":"Malkowicz","year":"2007","journal-title":"Urology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data","volume":"48","author":"Vale","year":"2005","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.09.027","article-title":"Defining optimal therapy for muscle invasive bladder cancer","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.115","article-title":"Prognostic value of sarcopenia in lung cancer","volume":"156","author":"Yang","year":"2019","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01122-y","article-title":"Gastric cancer with sarcopenia: an area worth focusing on","volume":"24","author":"Xie","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12468","article-title":"Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis","volume":"10","author":"Ubachs","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i12.2302","article-title":"Sarcopenia in pancreatic cancer: Effect on patient outcomes","volume":"14","author":"Choi","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i7.1188","article-title":"Sarcopenia in patients with colorectal cancer: A comprehensive review","volume":"8","author":"Vergara-Fernandez","year":"2020","journal-title":"World J Clin Cases"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101594","article-title":"The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis","volume":"14","author":"Kova\u010d","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101964","article-title":"Sarcopenia defined by the psoas muscle mass or quality is associated with poor survival in patients with aortic aneurysm undergoing surgery: A meta-analysis","volume":"88","author":"Geng","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12893-023-02085-5","article-title":"Predictive value of total psoas muscle index for postoperative physical functional decline in older patients undergoing emergency abdominal surgery","volume":"23","author":"Yamaguchi","year":"2023","journal-title":"BMC Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12831","article-title":"Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review","volume":"12","author":"McGovern","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B17","doi-asserted-by":"publisher","first-page":"194.e15","DOI":"10.1016\/j.urolonc.2021.11.002","article-title":"Impact of sarcopenia on outcomes of patients treated with trimodal therapy for muscle invasive bladder cancer","volume":"40","author":"Almarzouq","year":"2022","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061778","article-title":"Body composition of patients undergoing radical cystectomy for bladder cancer: sarcopenia, low psoas muscle index, and myosteatosis are independent risk factors for mortality","volume":"15","author":"Engelmann","year":"2023","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2023.14","article-title":"Sarcopenia is an independent predictor of survival undergoing radical cystectomy for bladder cancer: A single-center, retrospective study","volume":"76","author":"Erdik","year":"","journal-title":"Cent Eur J Urol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review: Methodological quality assessment tools","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid-Based Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clgc.2019.03.007","article-title":"Sarcopenia and response to neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"17","author":"Lyon","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112968","article-title":"Standardization of body composition status in patients with advanced urothelial tumors: the role of a CT-based AI-powered software for the assessment of sarcopenia and patient outcome correlation","volume":"15","author":"Borrelli","year":"2023","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.purol.2019.11.002","article-title":"La sarcop\u00e9nie est-elle un facteur de morbi-mortalit\u00e9 dans le traitement des tumeurs localis\u00e9es de la vessie infiltrant le muscle","volume":"30","author":"Fraisse","year":"2020","journal-title":"Prog En Urol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2018.0530","article-title":"Decrease in skeletal muscle index one year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer","volume":"45","author":"Ha","year":"2019","journal-title":"Int Braz J Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5606-4","article-title":"Sarcopenia as a novel preoperative prognostic predictor for survival in patients with bladder cancer undergoing radical cystectomy","volume":"23","author":"Hirasawa","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000477405","article-title":"Integrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomy","volume":"93","author":"Miyake","year":"2017","journal-title":"Oncology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12885-017-3231-7","article-title":"Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder","volume":"17","author":"Miyake","year":"2017","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.11.088","article-title":"Mortality after Radical Cystectomy: Impact of Obesity Versus Adiposity after Adjusting for Skeletal Muscle Wasting","volume":"193","author":"Psutka","year":"2015","journal-title":"J Urol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality: Sarcopenia and Survival After RC for UC","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.08.013","article-title":"Psoas muscle mass can predict postsurgical outcomes in patients who undergo radical cystectomy and urinary diversion reconstruction","volume":"158","author":"Stangl-Kremser","year":"2021","journal-title":"Urology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.07.015","article-title":"Sarcopenia evaluated using the skeletal muscle index is a significant prognostic factor for metastatic urothelial carcinoma","volume":"14","author":"Taguchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724536","article-title":"Combination of total psoas index and albumin\u2013globulin score for the prognosis prediction of bladder cancer patients after radical cystectomy: A population-based study","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14569","article-title":"Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer","volume":"28","author":"Yamashita","year":"2021","journal-title":"Int J Urol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/BLC-160080","article-title":"Change in psoas muscle volume as a predictor of outcomes in patients treated with chemotherapy and radical cystectomy for muscle-invasive bladder cancer","volume":"3","author":"Zargar","year":"2017","journal-title":"Bladder Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.105","article-title":"Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population","volume":"10","author":"Mao","year":"2020","journal-title":"Clin Transl Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.04.003","article-title":"Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults","volume":"32","author":"Hamaguchi","year":"2016","journal-title":"Nutrition"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-017-0983-3","article-title":"Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population","volume":"22","author":"Derstine","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1642833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:11Z","timestamp":1758168731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1642833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":44,"alternative-id":["10.3389\/fonc.2025.1642833"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1642833","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1642833"}}